Treatment of cutaneous leishmaniasis with 20% paromomycin ointment

Journal of the European Academy of Dermatology and Venereology

Volumn 13, Issue 3, 1999, Pages 214-217

  Stanimirovic A ^a   Stipic T ^b   Skerlev, M ^c   Basta Juzbasic A ^c  

^a NovaDerm Polyclin Dermatol V   (Croatia)

^b Vukovar General Hospital   (Croatia)

^c UNIVERSITY OF ZAGREB   (Croatia)

Author keywords

Croatia; Cutaneous leishmaniasis; Paromomycin; Topical therapy

Indexed keywords

PAROMOMYCIN;

ARTICLE; CASE REPORT; CROATIA; DOSE RESPONSE; ERYTHEMA; HUMAN; HUMAN TISSUE; HYPERKERATOSIS; HYPERPIGMENTATION; LEISHMANIA INFANTUM; LEISHMANIA MAJOR; LEISHMANIA TROPICA; MALE; PAPULE; PRESCHOOL CHILD; PRIORITY JOURNAL; SKIN LEISHMANIASIS; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, CUTANEOUS; ANIMALS; ANTI-BACTERIAL AGENTS; ANTIGENS, PROTOZOAN; ANTIPROTOZOAL AGENTS; CHILD, PRESCHOOL; CROATIA; FACIAL DERMATOSES; HUMANS; HYPERPIGMENTATION; LEISHMANIA; LEISHMANIASIS, CUTANEOUS; MALE; OINTMENTS; PAROMOMYCIN; REMISSION INDUCTION;

EID: 0032743130     PISSN: 09269959     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0926-9959(99)00086-0     Document Type: Article

References (14)

1. Stipic V. Skin infections caused by protozoa. In: Dobric I, editor. Dermatovenerologija, Zagreb: Dobric & Grafoplast, 1994. pp. 101-102.
2. Braun-Falco O, Wolff HH, Plewig G, Winkelmann RK. Diseases caused by protozoa. In: Braun-Falco O, Plewig G, Wolff HH, Winkelmann RK, editors. Dermatology, Berlin: Springer-Verlag, 1991. pp. 201-203.
3. Hepburn NC. Cutaneous leishmaniasis. Pt. II. Historical aspects, epidemiology and prevention. Proc R Coll Physicians Edinb 1993;(23):140-150.
4. Gregurek-Novak T, Cajkovac V, Belicza M. Osteomyelitis caused by Leishmania. Acta Derm Lug 1988;15:31-36.
5. Kuba R, Al-Gindany RL, El-Hassan AM, Omer AMS. Clinical diagnosis of cutaneous leishmaniasis (oriental sore). J Am Acad Dermatol 1987;16:1183-1189.
6. Herwald BL, Berman JD. Recommendations for treating leishmaniasis with sodium stibogluconate (Pentostam) and review of pertinent clinical studies. Am J Trop Med Hyg 1992;46:296-306.
7. Moss JT, Wilson JP. Current treatment recommendations for leishmaniasis. Ann Pharmacother 1992;26:1452-1455.
8. Scott JA, Davidson RN, Moody AH, et al. Aminosidine (paromomycin) in the treatment of leishmaniasis imported into the United Kingdom. Trans R Soc Trop Med Hyg 1992;86:617-619.
9. Bryceson AD, Murphy A, Moody AH. Treatment of 'Old World' cutaneous leishmaniasis with aminosidine ointment: results of an open study in London. Trans R Soc Trop Med Hyg 1994;88:226-228.
10. Neal RA, Murphy AG, Olliaro P, Croft SL. Aminosidine ointments for the treatment of experimental cutaneous leishmaniasis. Trans R Soc Trop Med Hyg 1994;88:223-225.
11. el-On J, Livshin R, Paz ZE, Weinrauch L. Topical treatment of cutaneous leishmaniasis. Br Med J (Clin Res Ed) 1985;291:1280-1281.
12. el-On J, Halevy S, Grunwal MH, Weinrauch L. Topical treatment of Old World cutaneous leishmaniasis caused by Leishmania major: a double blind control study. J Am Acad Dermatol 1992;27:227-231.
13. Asilian A, Jalayer T, Whitworth JA, et al. A randomized, placebo-controlled trial of a two-week regimen of aminosidine (paromomycin) ointment for treatment of cutaneous leishmaniasis in Iran. Am J Trop Med Hyg 1995;53:648-651.
14. Ben-Salah A, Zakraoui H, Zaatour A, et al. A randomized, placebo-controlled trial in Tunisia treating cutaneous leishmaniasis with paromomycin ointment. Am J Trop Med Hyg 1995;53:162-166.